Figure 5.
Number of infiltrating MNC subsets to exocrine pancreatic tissues and islets of FT1DM and nondiabetic control. (A) Number of CD45+ MNCs in the exocrine pancreas of FT1DM and control groups. (B) Number of CD3+ T cells in the exocrine pancreas of FT1DM and control groups. (C) Number of CD8+ T cells in the exocrine pancreas of FT1DM and control groups. (D) Number of CD4+ T cells in the exocrine pancreas of FT1DM and control groups. (E) Number of CD68+ macrophages in the exocrine pancreas of FT1DM and control groups. (F) Number of CD11c+ dendritic cells in the exocrine pancreas of FT1DM and control groups.

Number of infiltrating MNC subsets to exocrine pancreatic tissues and islets of FT1DM and nondiabetic control. (A) Number of CD45+ MNCs in the exocrine pancreas of FT1DM and control groups. (B) Number of CD3+ T cells in the exocrine pancreas of FT1DM and control groups. (C) Number of CD8+ T cells in the exocrine pancreas of FT1DM and control groups. (D) Number of CD4+ T cells in the exocrine pancreas of FT1DM and control groups. (E) Number of CD68+ macrophages in the exocrine pancreas of FT1DM and control groups. (F) Number of CD11c+ dendritic cells in the exocrine pancreas of FT1DM and control groups.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close